
Fiona Rutherford
U.S. Healthcare Reporter at Bloomberg News
Bloomberg News Reporter / [email protected]
Articles
-
2 weeks ago |
infobae.com | Fiona Rutherford
Un científico de Harvard especializado en adicciones y un exabogado del Gobierno instan al Departamento de Justicia de Estados Unidos a rechazar un plan que suavizaría las restricciones federales sobre el cannabis, con el que el sector ha contado para hacer crecer sus negocios.
-
2 weeks ago |
bostonglobe.com | Fiona Rutherford
A Harvard addiction scientist and a former government lawyer are urging the US Department of Justice to reject a plan that would ease federal restrictions on cannabis, which the industry has been counting on to grow their businesses. In a new paper published Wednesday in JAMA Psychiatry, the authors argue that the Biden administration’s push to reclassify cannabis relied on flawed reasoning and downplayed health risks, including cannabis-use disorder and links to psychosis.
-
2 weeks ago |
news.bloombergtax.com | Fiona Rutherford
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
-
2 weeks ago |
news.bloomberglaw.com | Fiona Rutherford
A Harvard addiction scientist and a former government lawyer are urging the US Department of Justice to reject a plan that would ease federal restrictions on cannabis, which the industry has been counting on to grow their businesses. In a new paper published Wednesday in JAMA Psychiatry, the authors argue that the Biden administration’s push to reclassify cannabis relied on flawed reasoning and downplayed health risks, including cannabis-use disorder and links to psychosis.
-
2 weeks ago |
bloomberg.com | Fiona Rutherford
Rescheduling would move cannabis into a lower-risk category, recognizing its potential medical use. (Bloomberg) -- A Harvard addiction scientist and a former government lawyer are urging the US Department of Justice to reject a plan that would ease federal restrictions on cannabis, which the industry has been counting on to grow their businesses.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 7K
- Tweets
- 6K
- DMs Open
- Yes

RT @ZSchneeweiss: Europeans saw Trump’s trade war coming and gorged on US booze https://t.co/09Hheyqn5i via @Fi_Rutherford https://t.co/BSz…

RT @MikeDorning: How Trump's policies are hurting beer sales. @Fi_Rutherford @sabahmeddings via @economics Gift Link: https://t.co/7kbeYLz…

RT @ZSchneeweiss: US whiskey makers look to flood EU market ahead of 50% tariffs https://t.co/xf5telicGJ via @Fi_Rutherford https://t.co/kO…